|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2001-6-1
|
|
pubmed:abstractText |
To determine whether consolidation therapy with high-dose melphalan, etoposide, and total-body irradiation (TBI) with autologous stem-cell support would improve the prognosis for patients with newly diagnosed metastatic Ewing's sarcoma (ES).
|
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/CA 02971,
http://linkedlifedata.com/resource/pubmed/grant/CA 03750,
http://linkedlifedata.com/resource/pubmed/grant/CA 05426,
http://linkedlifedata.com/resource/pubmed/grant/CA 07306,
http://linkedlifedata.com/resource/pubmed/grant/CA 13539,
http://linkedlifedata.com/resource/pubmed/grant/CA 14560,
http://linkedlifedata.com/resource/pubmed/grant/CA 17829,
http://linkedlifedata.com/resource/pubmed/grant/CA 26044,
http://linkedlifedata.com/resource/pubmed/grant/CA 26126,
http://linkedlifedata.com/resource/pubmed/grant/CA 27678,
http://linkedlifedata.com/resource/pubmed/grant/CA 28882,
http://linkedlifedata.com/resource/pubmed/grant/CA03888
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:BakerD LDL,
pubmed-author:ChanK WKW,
pubmed-author:DavisJ HJH,
pubmed-author:DickmanP SPS,
pubmed-author:GerbingR BRB,
pubmed-author:GorlickR GRG,
pubmed-author:GrovasAA,
pubmed-author:HerzogC ECE,
pubmed-author:KrailoM DMD,
pubmed-author:LadanyiMM,
pubmed-author:LindsleyK LKL,
pubmed-author:Liu-MaresWW,
pubmed-author:MeyersP APA,
pubmed-author:NachmanJ BJB,
pubmed-author:SailerS LSL,
pubmed-author:SiegerLL,
pubmed-author:WadmanJJ
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2812-20
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11387352-Adolescent,
pubmed-meshheading:11387352-Adult,
pubmed-meshheading:11387352-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11387352-Bone Neoplasms,
pubmed-meshheading:11387352-Child,
pubmed-meshheading:11387352-Child, Preschool,
pubmed-meshheading:11387352-Disease Progression,
pubmed-meshheading:11387352-Dose-Response Relationship, Drug,
pubmed-meshheading:11387352-Etoposide,
pubmed-meshheading:11387352-Female,
pubmed-meshheading:11387352-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:11387352-Humans,
pubmed-meshheading:11387352-Infant,
pubmed-meshheading:11387352-Male,
pubmed-meshheading:11387352-Melphalan,
pubmed-meshheading:11387352-Neoplasm Metastasis,
pubmed-meshheading:11387352-Prognosis,
pubmed-meshheading:11387352-Sarcoma, Ewing,
pubmed-meshheading:11387352-Transplantation, Autologous,
pubmed-meshheading:11387352-Treatment Outcome,
pubmed-meshheading:11387352-Whole-Body Irradiation
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis.
|
|
pubmed:affiliation |
Memorial Sloan-Kettering Cancer Center, New York, NY, USA. meyersp@mskcc.org
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Multicenter Study
|
